U.S. Markets open in 45 hrs, 11 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 40.12 04:21 PM EDT | |
|---|---|---|
| Day High | 40.48 04:04 PM EDT |
|
| Range | 0.36 |
| Volume | 657,260 | |
|---|---|---|
| 30-Day Avg Vol | 1.26 M |
|
| Difference | -48.21% |
| Market Cap | 90.86 B | |
|---|---|---|
| Mkt Cap Chg | -2.67 B |
| Shares Out | 2.26 B | |
|---|---|---|
| % Shrs Traded | 0.03% | |
| 1yr EPS Est | 3.68 |
| 52-Wk Low | 33.3424 3/4/09 | |
|---|---|---|
| 52-Wk High | 61.30 8/4/08 |
|
| Range | 27.96 |
| Prev Close | 41.30 7/1/09 | |
|---|---|---|
| Today's Open | 40.48 | |
| Change | -1.99% |
| Dividend (TTM) | 1.72012 | |
|---|---|---|
| Div Yield (TTM) | 4.16% | |
| Ex-Div Date | 02/24/2009 | |
| Div Date | 04/06/2009 |
|
| Short Interest | 4.3 M |
| Revenue (LFY) | 41.69 B | |
|---|---|---|
| Earnings (LFY) | 8.24 B | |
| Earnings (MRQ) | 1.87 B | |
| Next Earn Est | 0.863 | |
| Next Earnings | 10/22/2009 |
|
| EPS (TTM) | 3.40384 | |
| 1yr EPS Growth | 7.29% |
| P/E Ratio (TTM) | 11.27 | |
|---|---|---|
| P/E Ratio (Fwd) | 10.00 | |
| PEG Ratio | 4.35 | |
| Return on Equity | 14.39 | |
| Beta | 0.48 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Although it's based in neutral Switzerland, Novartis has been aggressive in attacking illnesses on four fronts: pharmaceuticals, vaccines and diagnostics, generics, and consumer health. Its largest division, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.863 N/A | — — |
—
—
|
| Last Quarter | 0.873 3/31/09 | 0.87 3/31/09 |
-0.003
Missed
|
| 2 Quarters Ago | 0.788 12/31/08 | 0.66 12/31/08 |
-0.128
Missed
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 9.25 B | 41.69 B |
| Gross Profit | 6.74 B | 30.20 B |
| Operating Income | 2.02 B | 8.14 B |
| Net Income | 1.87 B | 8.24 B |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts